AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Keeping pace.
June 1, 2007... Keeping pace
Innovative methods for treating atrial fibrillation and other rhythm problems keep growing — but so do the many questions
By LARRY HAIMOVITCH
Cardiovascular Device Update Contributing Editor
And Don Long,...
Report seeks greater rigor for catheter ablation of AF.
June 1, 2007... Report seeks greater rigor for catheter ablation of AF
By DON LONG
Cardiovascular Device Update Executive Editor
DENVER — Interventional cardiologists using catheters to treat atrial fibrillation (AF) may be treading on...
Ablation growing into 'tailor-made' approach for AF.
June 1, 2007... Ablation growing into 'tailor-made' approach for AF
By MARK McCARTY
CDU Washington Editor
The concept of "one size fits all" is falling more out of favor every day in modern medicine, and a presentation at the 87th annual meeting...
Acorn gets FDA okay for new trial of CorCap device.
June 1, 2007... Acorn gets FDA okay for new trial of CorCap device
By AMANDA PEDERSEN
CDU Staff Writer
When an FDA panel voted in June 2005 against recommending approval of Acorn Cardiovascular's (New Brighton, Minnesota) CorCap cardiac support...
International report.
June 1, 2007... International Report
Specialist heart centers superior in providing primary angioplasty
Research presented last month at the annual scientific conference of the British Cardiovascular Society shows that many heart attack patients are...
Deals/Acquisitions.
June 1, 2007... Deals/Acquisitions
• Boston Scientific (Natick, Massachusetts) is considering selling off pieces of its business to pay down about $7.2 billion in debt the company recently told shareholders. "There are some pieces of Boston...
Business developments.
June 1, 2007... Business developments
Johnson & Johnson hit by failure of CoStar to meet endpoints
The race to develop and commercialize a second-generation drug-eluting stent (DES) is poised to heat up in the second half of this year. Johnson &...
Research notes.
June 1, 2007... Research notes
Same-day angiography, valve surgery safe, Mayo study reports
Reporting in a recent issue of Mayo Clinic Proceedings, researchers at the Mayo Clinic (Rochester, New York) determine that it is safe, more convenient and...
Personnel file.
June 1, 2007... Personnel file
• Jeremy Curtis has been named VP of worldwide marketing of ATS Medical (Minneapolis), a manufacturer of proucts and services for cardiac surgery. Curtis most recently was general manager, diagnostic cardiology...
Product Pipelines.
June 1, 2007... Product Pipeline
8,800-patient trial pits Medtronic's Endeavor vs. Cordis' Cypher
For the past year drug-eluting stents (DES) have raised concerns about blood clots, damaging sales of FDA-approved DES devices — in the U.S., the...
At press time … Abbott submits last module for approval of Xience V DES.(Abbott Laboratories (Abbott Park, Illinois))(Drug Eluting Stent)(Food and Drug Administration)
June 1, 2007... At press time … Abbott submits last module for approval of Xience V DES
By HOLLAND JOHNSON
Cardiovascular Device Update Managing Editor
Abbott Laboratories (Abbott Park, Illinois) last week reported completing final...